MindWalk’s Computational Breakthrough Advances Universal Dengue Vaccine Development
Biotechnology firm MindWalk announced this week that its proprietary HYFT® computational platform has successfully predicted immunogens capable of generating cross-reactive antibodies against all four serotypes of the dengue virus. The preclinical study, which spanned two independent research campaigns, confirms that synthetic proteins designed through this digital modeling process can effectively trigger immune responses across the…